Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Mario Ernest
Relationship:   Director
City:   Redwood City
State:   CA
   
Insider Summary:
  
   
Companies Owned :   13    
Direct Shares   1,089,697    

Indirect Shares

   264,473      
Direct Value   $8,309,557    

Indirect Value

   $120,004      
Total Shares   1,354,170      
Total Value   $8,429,560      


Maxygen Inc $0 Ardea Biosciences Inc $0 Boston Scientific Corp $6,422,289 Alexza Pharmaceuticals Inc. $0 Vivus Inc $9,524 Xenoport Inc $0 Chimerix Inc $12,744 Kindred Biosciences, Inc. $1,563,250 Soleno Therapeutics Inc $19,980 Eyenovia Inc $281,770 Maxygen Inc $0 Ardea Biosciences Inc $0 Boston Scientific Corp $6,422,289 Alexza Pharmaceuticals Inc. $0 Vivus Inc $9,524 Xenoport Inc $0 Chimerix Inc $12,744 Kindred Biosciences, Inc. $1,563,250 Soleno Therapeutics Inc $19,980 Eyenovia Inc $281,770
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    3   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -41.7%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Maxygen Inc MAXY Director 2012-06-06 62,964 2003-08-05 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2004-05-05 70,431 2004-05-05 85,554    Premium*  
            Pharmaceutical Product Developme... PPDI Director 2011-12-05 0 2011-12-05 0    Premium*  
            Boston Scientific Corp BSX Director 2015-11-16 86,032 2013-11-08 0    Premium*  
            Alexza Pharmaceuticals Inc. ALXA Director 2006-03-08 18,181 0    Premium*  
            Celgene Corp CELG 2019-11-20 0 2019-11-20 0    Premium*  
            Vivus Inc VVUS Director 2013-05-29 81,125 2012-04-25 0    Premium*  
            Xenoport Inc XNPT Director 2015-05-19 88,750 2012-08-09 0    Premium*  
            Tonix Pharmaceuticals Holding Corp TNXP Director 2018-02-09 0 2018-06-25 50,000    Premium*  
            Chimerix Inc CMRX Director 2018-05-18 12,905 2018-05-18 108,167    Premium*  
            Kindred Biosciences, Inc. KIN Director 2018-10-29 169,000 2013-12-12 0    Premium*  
            Soleno Therapeutics Inc SLNO Director 2024-01-08 124,566 2024-01-08 20,752    Premium*  
            Eyenovia Inc EYEN Director 2021-01-15 375,743 2018-07-24 0    Premium*  
* Premium Members only  

Records found :    372         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 15
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CMRX Chimerix Inc Director   –       •      –    2013-08-16 4 B $17.45 $34,900 D/D 2,000 2,000 2.39 -
CMRX Chimerix Inc Director   –       •      –    2013-08-19 4 B $17.50 $35,000 D/D 2,000 4,000 2.39 -
CMRX Chimerix Inc Director   –       •      –    2013-08-20 4 B $17.50 $700 D/D 40 4,040 2.31 -
CMRX Chimerix Inc Director   –       •      –    2013-08-29 4 B $15.80 $66,706 D/D 4,214 14,214 2.39 -
CMRX Chimerix Inc Director   –       •      –    2013-08-30 4 B $15.75 $13,427 D/D 850 15,064 2.39 -
XNPT Xenoport Inc Director   –       •      –    2013-09-27 4 OE $5.79 $108,563 D/D 18,750 48,750 0 -
CELG Celgene Corp Director   –       •      –    2013-10-24 4 OE $59.89 $359,340 D/D 6,000 91,671 0 -
BSX Boston Scientific Corp Director   •       •      –    2013-11-08 4 S $11.73 $1,351,503 D/D (115,200) 394,959 0 -
BSX Boston Scientific Corp Director   •       •      –    2013-11-08 4 S $11.73 $239,857 I/I (20,445) 0 0 -
CMRX Chimerix Inc Director   –       •      –    2013-11-19 4 B $15.25 $114,375 D/D 7,500 22,564 2.39 -
CMRX Chimerix Inc Director   –       •      –    2013-11-19 4 OE $5.05 $79,992 D/D 15,840 38,404 0 -
CMRX Chimerix Inc Director   –       •      –    2013-11-25 4 B $15.20 $121,600 D/D 8,000 46,404 2.39 -
KIN Kindred Biosciences, Inc. Director   –       •      –    2013-12-12 4 B $7.00 $175,000 D/D 25,000 25,000 2.39 -
CMRX Chimerix Inc Director   –       •      –    2013-12-13 4 B $13.90 $69,500 D/D 5,000 51,404 2.39 -
BSX Boston Scientific Corp Director   •       •      –    2013-12-26 4 AS $12.06 $120,600 D/D (10,000) 384,959 0 -
BSX Boston Scientific Corp Director   •       •      –    2014-01-06 4 AS $12.50 $125,000 D/D (10,000) 374,959 0 -
CELG Celgene Corp Director   –       •      –    2014-01-07 4 OE $59.89 $119,780 D/D 2,000 93,671 0 -
BSX Boston Scientific Corp Director   •       •      –    2014-02-03 4 AS $13.19 $131,884 D/D (10,000) 364,959 0 -
CELG Celgene Corp Director   –       •      –    2014-02-04 4 OE $60.02 $420,140 D/D 7,000 100,671 0 -
CELG Celgene Corp Director   –       •      –    2014-02-05 4 S $151.87 $2,050,284 D/D (13,500) 100,671 0 -
CELG Celgene Corp Director   –       •      –    2014-02-05 4 OE $59.89 $845,761 D/D 13,500 114,171 0 -
KIN Kindred Biosciences, Inc. Director   –       •      –    2014-02-05 4 OE $0.32 $4,000 D/D 12,500 37,500 0 -
BSX Boston Scientific Corp Director   •       •      –    2014-02-06 4 S $12.80 $218,935 D/D (17,104) 347,855 0 -
CELG Celgene Corp Director   –       •      –    2014-02-18 4 GD $0.00 $0 I/I 1,020 4,980 0 -
CELG Celgene Corp Director   –       •      –    2014-02-18 4 GD $0.00 $0 D/D 1,020 226,764 0 -
  372  Records found
  1   2   3   4   5   6   7  8   9   10   11   12   13   14   15      
  Page 7 of 15  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us